AI assistant
SURMODICS INC — Director's Dealing 2018
May 29, 2018
32845_dirs_2018-05-29_1f372488-4455-4af2-a7f0-53b31767edc8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-05-24
Reporting Person: OLSON CHARLES W (Senior VP of Bus Dev, Med Dev)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-24 | Common Stock | S | 18760 | $48.4827 | Disposed | 33467 | Direct |
| 2018-05-24 | Common Stock | S | 1240 | $49.3923 | Disposed | 32227 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 800 | Indirect |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.
F2: Reflects the weighted average price of 18,760 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 24, 2018 with sale prices ranging from $48.25 to $49.15 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 1,240 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on May 24, 2018 with sale prices ranging from $49.30 to $49.425 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.